Announcements

Call for Nominations for the 2026 Innovations in Regulatory Science & Policy Awards
The Reagan-Udall Foundation for the FDA invites nominations for its annual Innovations in Regulatory Science & Policy Awards.
Read More
Reagan-Udall Foundation for the FDA Announces New Board Chair; Welcomes New Board Member
(February 6, 2026) The Reagan-Udall Foundation for the FDA (Foundation) has appointed Adrian F. Hernandez, MD, MHS, as Chair of its Board of Directors. Dr. Hernandez, who has served on the Board since 2019, is a cardiologist and the Vice Dean for…
Read More
Produce Safety Alliance, Critical Path Institute, and Loren A. Eng Recognized with Innovations in Regulatory Science & Policy Awards
The Reagan-Udall Foundation for the FDA will honor the Produce Safety Alliance, Critical Path Institute, and Loren A. Eng with its Innovations in Regulatory Science & Policy Awards on December 9, 2025.
Read More
More Announcements

Coverage

FDA: FDA Releases Blueprint to Expand Animal Drug Development for Minor Uses and Minor Species
The Blueprint’s four strategic goals are shaped by input from across the animal health community, including findings from the Reagan-Udall Foundation's Transforming Animal Health in the U.S. for the 21st Century report and the AVMA MUMS Roundtable…
Read More
Gene Online: BIO CEO John F. Crowley on Unifying Regulation, Artificial Intelligence, and National Security into a Singular Competitiveness Agenda in Bio Sector
This sustained political advocacy culminated in the formal endorsement of the FDA’s new Project Trailblazer initiative, a milestone heavily shaped by collaborative efforts between BIO’s regulatory teams and the Reagan-Udall Foundation in Washington.
Read More
BIO.News: New report details how U.S. can maintain biotech competitiveness
The Reagan-Udall Foundation for the FDA just released a new report on strengthening early-stage drug development in the United States.
Read More
More Coverage